Your browser doesn't support javascript.
loading
Prevalence of HIV drug resistance in Nigeria: results from a cross-sectional, population-based survey of Nigerian adults with unsuppressed viral load.
Aliyu, Gambo G; Lawton, Jonathan G; Mitchell, Andrew B; Abimiku, Alash'le G; Jelpe, Tapdiyel; Bassey, Orji; Riedel, David J; Swaminathan, Mahesh; Chang, Joy Chih-Wei; DeVos, Joshua R; Patel, Hetal; Charurat, Man E; Stafford, Kristen A.
Afiliação
  • Aliyu GG; National Agency for the Control of AIDS, Abuja, Nigeria.
  • Lawton JG; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD.
  • Mitchell AB; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Abimiku AG; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Jelpe T; Institute of Human Virology-Nigeria.
  • Bassey O; Division of Global HIV & TB, Department of Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Riedel DJ; Division of Global HIV & TB, Department of Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Swaminathan M; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Chang JC; Division of Global HIV & TB, Department of Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria.
  • DeVos JR; International Laboratories Branch, Department of Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Patel H; International Laboratories Branch, Department of Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Charurat ME; International Laboratories Branch, Department of Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Stafford KA; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
AIDS ; 37(2): 333-339, 2023 02 01.
Article em En | MEDLINE | ID: mdl-36541644
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Africa Idioma: En Revista: AIDS Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Nigéria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Africa Idioma: En Revista: AIDS Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Nigéria